Criteria for prioritisation of CTC requests for 2WW colorectal cancer referrals during the COVID-19 recovery period
FIT result . | . | Blood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109 l−1 . | Priority . |
---|---|---|---|
>100–149.9 µg Hb/g | Ignore | ASAP | |
>20–99.9 µg Hb/g | & | Abnormal | 1 |
>4–20 µg Hb/g | Abnormal | 2 | |
>20–99.9 µg Hb/g | Normal | 3 | |
>4–20 µg Hb/g | Normal | Discharge back to referrer |
FIT result . | . | Blood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109 l−1 . | Priority . |
---|---|---|---|
>100–149.9 µg Hb/g | Ignore | ASAP | |
>20–99.9 µg Hb/g | & | Abnormal | 1 |
>4–20 µg Hb/g | Abnormal | 2 | |
>20–99.9 µg Hb/g | Normal | 3 | |
>4–20 µg Hb/g | Normal | Discharge back to referrer |
CTC, CT colonography; FIT, faecal-immunochemical test; 2WW, 2-week wait.
Criteria for prioritisation of CTC requests for 2WW colorectal cancer referrals during the COVID-19 recovery period
FIT result . | . | Blood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109 l−1 . | Priority . |
---|---|---|---|
>100–149.9 µg Hb/g | Ignore | ASAP | |
>20–99.9 µg Hb/g | & | Abnormal | 1 |
>4–20 µg Hb/g | Abnormal | 2 | |
>20–99.9 µg Hb/g | Normal | 3 | |
>4–20 µg Hb/g | Normal | Discharge back to referrer |
FIT result . | . | Blood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109 l−1 . | Priority . |
---|---|---|---|
>100–149.9 µg Hb/g | Ignore | ASAP | |
>20–99.9 µg Hb/g | & | Abnormal | 1 |
>4–20 µg Hb/g | Abnormal | 2 | |
>20–99.9 µg Hb/g | Normal | 3 | |
>4–20 µg Hb/g | Normal | Discharge back to referrer |
CTC, CT colonography; FIT, faecal-immunochemical test; 2WW, 2-week wait.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.